To Örebro University

oru.seÖrebro University Publications
Change search
Link to record
Permanent link

Direct link
Alternative names
Publications (10 of 151) Show all publications
Guerreiro, C. d., Andrade, L. A. .., Fernández-Lainez, C., Fraga, L. N., López-Velázquez, G., Marques, T. M., . . . Castro Alves, V. (2025). Bioactive arabinoxylan oligomers via colonic fermentation and enzymatic catalysis: Evidence of interaction with toll-like receptors from in vitro, in silico and functional analysis. Carbohydrate Polymers, 352, Article ID 123175.
Open this publication in new window or tab >>Bioactive arabinoxylan oligomers via colonic fermentation and enzymatic catalysis: Evidence of interaction with toll-like receptors from in vitro, in silico and functional analysis
Show others...
2025 (English)In: Carbohydrate Polymers, ISSN 0144-8617, E-ISSN 1879-1344, Vol. 352, article id 123175Article in journal (Refereed) Published
Abstract [en]

Dietary fibers (DF) from plant-based foods promote health benefits through their physicochemical properties and fermentation by the gut microbiota, often studied in relation to changes in gut microbiota profile and production of gut microbiota-derived metabolites. Here, we characterized structural motifs (i.e., oligomers) produced during DF breakdown upon colonic fermentation and explored their interaction with toll-like receptors (TLRs) present on the surface of human intestinal and immune system cells. Wheat arabinoxylan (WAX) was subjected to in vitro colonic fermentation, with its structural motifs identified and tracked throughout the fermentation process. Using carbohydrate-active enzymes, six well-defined fractions of arabinoxylans and linear xylans identified during colonic fermentation were produced and tested for interaction with tool-like receptors (TLR)2 and TLR4 via reporter cell assay. The results showed structure-dependent effects, with TLR2 inhibition and TLR4 activation varying based on the degree of polymerization and branching. Molecular docking confirmed that minor structural changes in oligomers structure significantly influenced these interactions. The study supports the hypothesis that oligomers and polysaccharides affect cell receptors through complex, multi-receptor interactions, and highlights the potential for enzymatic tailoring of DF to create functional ingredients with targeted effects on human health.

Place, publisher, year, edition, pages
Elsevier, 2025
Keywords
Dietary fiber, Oligosaccharides, Mass spectrometry, Reporter cells, Toll-like receptors, Molecular docking
National Category
Food Science Analytical Chemistry
Identifiers
urn:nbn:se:oru:diva-118336 (URN)10.1016/j.carbpol.2024.123175 (DOI)2-s2.0-85213521726 (Scopus ID)
Funder
Swedish Research Council, 2021-04937
Note

We also thank the Research Internship Abroad program of the São Paulo Research Foundation (BEPE-FAPESP,#2022/08480-0) for providing financial support to Leandro Andrade. Molecular graphics and analyses performed with UCSF ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from National Institutes of Health R01-GM129325 and the Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases. This work was funded by a Starting Grant within Natural and Engineering Sciences of the Swedish Research Council(#2021-04937) and by the Lantmännen Research Foundation (#2022H004).

Available from: 2025-01-13 Created: 2025-01-13 Last updated: 2025-01-14Bibliographically approved
Dalile, B., Boyle, N. B., Ruiz, F. T., Chakrabarti, A., Respondek, F., Dodd, G. F., . . . Schellekens, H. (2025). Targeting cognitive resilience through prebiotics: A focused perspective. Advances in nutrition (Bethesda, Md.), 16(1), Article ID 100343.
Open this publication in new window or tab >>Targeting cognitive resilience through prebiotics: A focused perspective
Show others...
2025 (English)In: Advances in nutrition (Bethesda, Md.), ISSN 2161-8313, Vol. 16, no 1, article id 100343Article in journal (Refereed) Published
Abstract [en]

This perspective article is a product of the work of an expert group within the Prebiotic Task Force convened by the International Life Sciences Institute Europe (ILSI Europe), a non-profit organization that brings together experts from academia, industry and public service to catalyse nutrition science for public benefit. An expert group was conceived in October 2023 to discuss the evidence base on the use of prebiotics to promote cognitive functioning, with a focus on highlighting knowledge gaps and proposing a list of recommendations to guide this specific area of research forward. To address this, we evaluated existing systematic reviews and meta-analyses of human intervention studies that examine the effects of prebiotics on cognitive functioning. These are predominantly conducted in healthy participants under basal conditions and have, to date, revealed limited effects. In this perspective, we propose that prebiotics should be investigated as agents to promote cognitive resilience by testing their effects on cognitive performance under certain cognition-taxing factors that individuals encounter across their lifespan. These include stress, poor sleep outcomes, sedentary behaviour, and unhealthy dietary patterns, all of which have been shown to be associated with altered microbiome and impact global cognition or specific cognitive domains. In addition, we recommend identifying vulnerable populations that are either sub-clinical or that struggle chronically or periodically with one or more cognition-taxing factors, to better uncover the boundary conditions for prebiotic effectiveness. By broadening the scope of research to include diverse populations and challenging conditions in daily life or experimental settings, we can expand our understanding of the role of prebiotics not only in cognitive health or impairment, but also as potential preventative agents that may promote cognitive resilience during aging and in response to various lifestyle-related challenges.

Place, publisher, year, edition, pages
Oxford University Press, 2025
Keywords
Prebiotics, cognition, cognitive resilience, gut microbiota, gut-brain axis, nutritional interventions, sedentary behaviour, sleep, stress
National Category
Nutrition and Dietetics Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
urn:nbn:se:oru:diva-117405 (URN)10.1016/j.advnut.2024.100343 (DOI)001373873500001 ()39551433 (PubMedID)2-s2.0-85210720320 (Scopus ID)
Available from: 2024-11-18 Created: 2024-11-18 Last updated: 2025-01-13Bibliographically approved
Puhlmann, M.-L., van de Rakt, E., Kerezoudi, E. N., Rangel, I., Brummer, R. J., Smidt, H., . . . de Vos, W. M. (2024). Analysis of the fermentation kinetics and gut microbiota modulatory effect of dried chicory root reveals the impact of the plant-cell matrix rationalizing its conversion in the distal colon. Microbiome Research Reports, 3(3), Article ID 28.
Open this publication in new window or tab >>Analysis of the fermentation kinetics and gut microbiota modulatory effect of dried chicory root reveals the impact of the plant-cell matrix rationalizing its conversion in the distal colon
Show others...
2024 (English)In: Microbiome Research Reports, ISSN 2771-5965, Vol. 3, no 3, article id 28Article in journal (Refereed) Published
Abstract [en]

Aim: The cell matrix of plant foods has received little attention in prebiotic fiber research. We aimed to understand the impact of the plant cell matrix in dried chicory root on its breakdown in the human gut to explain its reported beneficial effects on gut and metabolic health.

Methods: We applied in vitro digestion and fermentation models together with an ex vivo gut barrier integrity model. Plant cell matrix intactness in the upper gastrointestinal tract was investigated by scanning electron microscopy. Colonic breakdown of inulin, and chicory root cubes and powder was assessed by gut microbiota analysis using 16S rRNA gene amplicon sequencing and determining the kinetics of changes in pH, gas, and short- chain fatty acid (SCFA) production. Finally, effects on gut barrier integrity were explored by exposing colonic biopsies to fermentation supernatants in an Ussing chamber model.

Results: The plant cell matrix of dried chicory root cubes remained intact throughout upper gastrointestinal transit. Dried chicory root fermentation resulted in higher final relative abundances of pectin-degrading Monoglobus and butyrate-producing Roseburia spp. compared to inulin and a seven-fold increase in Bifidobacterium spp. in donors where these species were present. Dried chicory root cubes yielded similar total SCFAs but higher final butyrate levels than chicory root powder or isolated inulin with less gas produced. No uniform but donor-specific effects of fermentation supernatants on the maintenance of gut barrier integrity were detected.

Conclusion: The intact plant cell matrix of dried chicory root affected its colonic breakdown kinetics and microbiota, underpinning its beneficial effect in vivo.

Place, publisher, year, edition, pages
OAE Publishing, 2024
Keywords
Plant cell wall, chicory root, intrinsic fiber, gut health, gut microbiota, colonic fermentation, butyrate production
National Category
Microbiology in the medical area
Identifiers
urn:nbn:se:oru:diva-116919 (URN)10.20517/mrr.2024.04 (DOI)001330464700003 ()39421250 (PubMedID)2-s2.0-85192813157 (Scopus ID)
Note

This work was partly supported by the unlimited 2008 Spinoza grant of the Netherlands Organization of Scientific Research (NWO) to de Vos WM and a VLAG fellowship grant 2.0 2022/23 to Puhlmann ML.

Available from: 2024-10-18 Created: 2024-10-18 Last updated: 2024-10-24Bibliographically approved
Roca Rubio, M. F., Folkesson, M., Kremp, C., Evertsson, N., Repsilber, D., Eriksson, U., . . . König, J. (2024). Associations between various markers of intestinal barrier and immune function after a high-intensity exercise challenge. Physiological Reports, 12(10), Article ID e16087.
Open this publication in new window or tab >>Associations between various markers of intestinal barrier and immune function after a high-intensity exercise challenge
Show others...
2024 (English)In: Physiological Reports, E-ISSN 2051-817X, Vol. 12, no 10, article id e16087Article in journal (Refereed) Published
Abstract [en]

Strenuous exercise can result in disruption of intestinal barrier function and occurrence of gastrointestinal symptoms. The aim of this exploratory study was to elucidate systemic effects of increased intestinal permeability after high-intensity exercise. Forty-one endurance-trained subjects performed a 60-min treadmill run at 80% VO2max. Small intestinal permeability was measured as urinary excretion ratio of lactulose/rhamnose (L/R). Blood, saliva and feces were analyzed for gut barrier and immune-related biomarkers. The exercise challenge increased several markers of intestinal barrier disruption, immune function and oxidative stress. We found a negative correlation between L/R ratio and uric acid (r = -0.480), as well as a positive correlation between the L/R ratio and fecal chromogranin A in male participants (r = 0.555). No significant correlations were found between any of the markers and gastrointestinal symptoms, however, perceived exertion correlated with the combination of IL-6, IL-10 and salivary cortisol (r = 0.492). The lack of correlation between intestinal permeability and gastrointestinal symptoms could be due to minor symptoms experienced in lab settings compared to real-life competitions. The correlation between L/R ratio and uric acid might imply a barrier-protective effect of uric acid, and inflammatory processes due to strenuous exercise seem to play an important role regarding physical exhaustion.

Place, publisher, year, edition, pages
John Wiley & Sons, 2024
Keywords
Gastrointestinal symptoms, high‐intensity exercise, intestinal barrier function, intestinal permeability
National Category
Gastroenterology and Hepatology
Identifiers
urn:nbn:se:oru:diva-113825 (URN)10.14814/phy2.16087 (DOI)001229765900001 ()38783385 (PubMedID)2-s2.0-85193921085 (Scopus ID)
Funder
Knowledge Foundation, 20110225
Note

The study was partially supported by the Knowledge Foundation Sweden (Grant reference number: 20110225) and Chr. Hansen A/S, Denmark.

Available from: 2024-05-24 Created: 2024-05-24 Last updated: 2024-06-04Bibliographically approved
Lentjes, M. A. H., Lönnström, S., Lobenius Palmér, K., Alsammarraie, Z., Lindroos, A. K., Sipinen, J. P., . . . Montgomery, S. (2024). Development of dietary assessment instruments which can take cultural diversity and dietary acculturation into account: eating in Sweden ('Mat i Sverige'). Journal of Nutritional Science, 13, Article ID e70.
Open this publication in new window or tab >>Development of dietary assessment instruments which can take cultural diversity and dietary acculturation into account: eating in Sweden ('Mat i Sverige')
Show others...
2024 (English)In: Journal of Nutritional Science, E-ISSN 2048-6790, Vol. 13, article id e70Article in journal (Refereed) Published
Abstract [en]

Since lack of culture-specific foods in dietary assessment methods may bias reported dietary intake, we identified foods and dishes consumed by residents not born in Sweden and describe consequences for reported foods and nutrient intake using a culturally adapted dietary assessment method. Design consisted of cross-sectional data collection using (semi-)qualitative methods of dietary assessment (and national diet survey instrument RiksmatenFlex) with subsequent longitudinal data collection using quantitative methods for method comparison (December 2020-January 2023). Three community-based research groups were recruited that consisted of mothers born in Sweden, Syria/Iraq, and Somalia, with a median age of 34, 37, and 36 years, respectively. Women born in Syria/Iraq and Somalia who had lived in Sweden for approximately 10 years, reported 78 foods to be added to RiksmatenFlex. In a subsequent study phase, 69% of these foods were reported by around 90% of the ethnic minority groups and contributed to 17% of their reported energy intake. However, differences between the three study groups in median self-reported energy intake remained (Sweden 7.19 MJ, Syria/Iraq 5.54 MJ, and Somalia 5.69 MJ). The groups also showed differences in relative energy contribution from fats and carbohydrates, as well as differences in energy intake from food groups such as bread and sweet snacks. We conclude that a dietary assessment instrument containing culture-specific foods could not resolve group differences in reported energy intake, although these foods provided content validity and contributed 17% of energy intake. The dietary habits collected in this study serve to develop new dietary assessment instruments.

Place, publisher, year, edition, pages
Cambridge University Press, 2024
Keywords
24h-diet recall, Content validity, Culture-specific food, Dietary acculturation, Dietary assessment
National Category
Nutrition and Dietetics
Identifiers
urn:nbn:se:oru:diva-117492 (URN)10.1017/jns.2024.72 (DOI)001355724100001 ()39588007 (PubMedID)2-s2.0-85209909801 (Scopus ID)
Funder
Örebro UniversityRegion Örebro County
Available from: 2024-11-28 Created: 2024-11-28 Last updated: 2024-12-06Bibliographically approved
Vumma, R., Rode, J., Yang, L., Montero, J., König, J., Wall, R., . . . Rangel, I. (2024). Exploring Therapeutic Strategies for Neuropsychiatric Disorders: Modulating Inflammation, Gut-Brain Interactions, and the Role of Butyrate. Paper presented at ASPET 2024 Annual Meeting - Neuropharmacology, Arlington, VA, USA, May 16-19, 2024.. Journal of Pharmacology and Experimental Therapeutics, 387(S3), Article ID 336.127906.
Open this publication in new window or tab >>Exploring Therapeutic Strategies for Neuropsychiatric Disorders: Modulating Inflammation, Gut-Brain Interactions, and the Role of Butyrate
Show others...
2024 (English)In: Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, E-ISSN 1521-0103, Vol. 387, no S3, article id 336.127906Article in journal, Meeting abstract (Refereed) Published
Place, publisher, year, edition, pages
American Society for Pharmacology and Experimental, 2024
Keywords
Neuropsychiatric Disorders
National Category
Medical and Health Sciences
Research subject
Psychiatry
Identifiers
urn:nbn:se:oru:diva-114769 (URN)10.1124/jpet.336.127906 (DOI)
Conference
ASPET 2024 Annual Meeting - Neuropharmacology, Arlington, VA, USA, May 16-19, 2024.
Available from: 2024-07-12 Created: 2024-07-12 Last updated: 2024-08-28Bibliographically approved
Rode, J., Brengesjö Johnson, L., König, J., Rangel, I., Engstrand, L., Repsilber, D. & Brummer, R. J. (2024). Fecal samples and rectal swabs adequately reflect the human colonic luminal microbiota. Gut microbes, 16(1), Article ID 2416912.
Open this publication in new window or tab >>Fecal samples and rectal swabs adequately reflect the human colonic luminal microbiota
Show others...
2024 (English)In: Gut microbes, ISSN 1949-0976, E-ISSN 1949-0984, Vol. 16, no 1, article id 2416912Article in journal (Refereed) Published
Abstract [en]

The appropriateness of the fecal microbiota to adequately reflect the gut microbiota composition from more difficult to access luminal content at different colonic locations has been debated. Here, in a healthy population, luminal samples were collected from terminal ileum to rectum using an unique sampling technique without the need of prior bowel cleansing/preparation. Rectal swabs were collected immediately prior colonoscopy by an experienced physician, and fecal samples were collected at home by the participants themselves. Microbiota composition was evaluated as relative abundance, α-diversity and Bray-Curtis dissimilarities. Our data suggest that fecal samples and rectal swabs present noninvasive, easily accessible, low-cost sampling tools that are accurate proxies to characterize luminal large intestinal microbiota composition.

Place, publisher, year, edition, pages
Taylor & Francis, 2024
Keywords
Gut microbiota, aspiration, feces, gut microbiome, intraluminal, rectal, sampling technique
National Category
Gastroenterology and Hepatology
Identifiers
urn:nbn:se:oru:diva-117026 (URN)10.1080/19490976.2024.2416912 (DOI)001339702800001 ()39439236 (PubMedID)2-s2.0-85207174680 (Scopus ID)
Funder
Swedish Research Council, 20230004-H-01
Available from: 2024-10-24 Created: 2024-10-24 Last updated: 2024-11-05Bibliographically approved
Vingeliene, S., Hiyoshi, A., Lentjes, M., Brummer, R. J., Fall, K. & Montgomery, S. (2024). Hospital-treated infections and subsequent Parkinson's disease risk: a register-based sibling comparison study. Brain Communications, 6(2), Article ID fcae098.
Open this publication in new window or tab >>Hospital-treated infections and subsequent Parkinson's disease risk: a register-based sibling comparison study
Show others...
2024 (English)In: Brain Communications, E-ISSN 2632-1297, Vol. 6, no 2, article id fcae098Article in journal (Refereed) Published
Abstract [en]

Serious infections may result in greater risk of Parkinson's disease. However, high-quality cohort studies focusing on a potential causal role of different types and sites of infection are lacking. Gastrointestinal infections are of a particular interest due to growing evidence implicating gut dysbiosis in Parkinson's disease aetiology. This population-based cohort study used the Swedish Total Population Register to identify individuals born during 1944-77 and resident in Sweden between 1990 and 2018 (N = 3 698 319). Hospital-treated infections at ages 21-30 and 31-40 years were identified from the National Patient Register. Participants were followed to identify Parkinson's disease diagnoses from age 41 years up to December 31, 2018, when the oldest individual reached 75 years. Cox regression with a sibling comparison design to tackle familial genetic and environmental confounding was used to derive hazard ratios and 95% confidence intervals for each infection site, type, or any infections at ages 21-30 and 31-40 years. During a median follow-up of 15.4 years, 8815 unique Parkinson's disease diagnoses were accrued, with a crude rate of 17.3 (95% confidence interval 17.0, 17.7) per 100 000 person-years. After controlling for shared familial factors, hospital-treated gastrointestinal and respiratory infections between 21 and 30 years of age were associated with a greater risk of Parkinson's disease [hazard ratios 1.35 (95% confidence interval: 1.05, 1.75) and 1.45 (95% confidence interval: 1.08, 1.95), respectively]; no association was found for any infections at age 31-40 [hazard ratio 1.05 (95% confidence interval: 0.93, 1.19)]. After adjustment, no statistically significant associations were observed for other sites including genitourinary and skin. These findings suggest that hospital-treated infections of the gastrointestinal tract and lungs, both of which may have an influence on the gut microbiome, by age 30 years may be risk factors for Parkinson's disease.

Place, publisher, year, edition, pages
Oxford University Press, 2024
Keywords
Cohort study, neurodegeneration
National Category
Gerontology, specialising in Medical and Health Sciences
Identifiers
urn:nbn:se:oru:diva-112916 (URN)10.1093/braincomms/fcae098 (DOI)001216872600001 ()38562309 (PubMedID)2-s2.0-85189693358 (Scopus ID)
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2019-01236Nyckelfonden
Note

This study was supported by grants from the Swedish Research Council for Health, Working Life and Welfare (Forte) (grant number 2019-01236), Nyckelfonden and the UK Economic and Social Research Council (ESRC) to the International Centre for Life Course Studies (ES/R008930/1).

Available from: 2024-04-08 Created: 2024-04-08 Last updated: 2024-07-23Bibliographically approved
Larsen, O. F. A. & Brummer, R. J. (2024). Perspective: on the future of fecal microbiota transplantation. Frontiers in Microbiology, 15, Article ID 1449133.
Open this publication in new window or tab >>Perspective: on the future of fecal microbiota transplantation
2024 (English)In: Frontiers in Microbiology, E-ISSN 1664-302X, Vol. 15, article id 1449133Article in journal (Refereed) Published
Abstract [en]

Fecal Microbiota Transplantation (FMT) has shown to possess impressive potential benefit for a wide range of clinical indications. Due to its inherent safety issues and efficacy constraints, the use of personalized FMT analogs could be a promising avenue. The development of such analogs will require a detailed understanding of their functionality, encompassing not only microbe-host interactions of the microbial taxa that are involved, but also of the ecological dimensions of the analogs and an overview of the gastrointestinal sites where these relevant microbial interactions take place. Moreover, characterization of taxa that have been lost due to diminished exposure to beneficial microbes, as a consequence of Western lifestyle, may lead to creation of future FMT analogs with the capacity to restore functionalities that we have lost.

Place, publisher, year, edition, pages
Frontiers Media S.A., 2024
Keywords
One Health, analogs, fecal microbiota transplantation, gut microbiota, personalized, probiotics
National Category
Gastroenterology and Hepatology
Identifiers
urn:nbn:se:oru:diva-116271 (URN)10.3389/fmicb.2024.1449133 (DOI)001317837000001 ()39314882 (PubMedID)2-s2.0-85204767043 (Scopus ID)
Available from: 2024-09-25 Created: 2024-09-25 Last updated: 2024-10-09Bibliographically approved
König, J., Roca Rubio, M. F., Forsgård, R. A., Rode, J., Axelsson, J., Grompone, G. & Brummer, R. J. (2024). The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT. PLOS ONE, 19(11), Article ID e0312464.
Open this publication in new window or tab >>The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT
Show others...
2024 (English)In: PLOS ONE, E-ISSN 1932-6203, Vol. 19, no 11, article id e0312464Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: An increased intestinal permeability is a common feature in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D). Probiotics have shown to improve IBS symptoms and might also affect intestinal barrier function.

AIM: The aim of this study was to investigate the effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone (single strain) or in combination with Limosilactobacillus reuteri DSM 17938 (dual strain) on gut barrier function, immune markers, and symptoms in IBS-D patients (ClinicalTrials.gov registration number: NCT03986476).

METHODS: 65 IBS-D patients were randomised into three groups (placebo, single strain, dual strain). Small and large intestinal permeability were assessed using a multi-sugar urinary recovery test. Blood, saliva, faecal samples, and several symptom scales were collected before, and after three and six weeks of intervention.

RESULTS: Small and large intestinal permeability as well as other markers of gut barrier function were not significantly affected by the probiotic interventions. Serum IL-6 levels showed a tendency to be reduced in the single strain group (descriptive p = 0.052). In addition, high-sensitivity C-reactive protein was significantly reduced in the dual strain group (p = 0.041). The participants in both treatment groups reported less gastrointestinal symptoms after three weeks, but this reached significance only in the dual strain group (total score: p = 0.032, pain subscore: p = 0.028). After six weeks, none of the assessed symptoms were significantly different from the placebo.

CONCLUSION: The probiotic compounds investigated in this study did not seem to affect IBS-D patients' gut barrier function, but showed potential anti-inflammatory and symptom-improving properties, which need to be confirmed in larger study cohorts.

Place, publisher, year, edition, pages
Public Library of Science (PLoS), 2024
National Category
Gastroenterology and Hepatology
Identifiers
urn:nbn:se:oru:diva-117163 (URN)10.1371/journal.pone.0312464 (DOI)001349429300037 ()39485760 (PubMedID)2-s2.0-85207960103 (Scopus ID)
Funder
Knowledge Foundation, 20110225
Note

Funding: RJB: 20110225, The Knowledge Foundation, Sweden, https://www.kks.se/en/start-en/ Part of the study was financed by BioGaia AB.

Available from: 2024-11-04 Created: 2024-11-04 Last updated: 2024-11-26Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-0362-0008

Search in DiVA

Show all publications